110 related articles for article (PubMed ID: 19151562)
61. The hidden sepsis marker: aPTT waveform analysis.
Dempfle CE; Borggrefe M
Thromb Haemost; 2008 Jul; 100(1):9-10. PubMed ID: 18612529
[No Abstract] [Full Text] [Related]
62. Incidence and pathogenesis of thrombosis in hematologic malignancies.
Kwaan HC; Vicuna B
Semin Thromb Hemost; 2007 Jun; 33(4):303-12. PubMed ID: 17525887
[TBL] [Abstract][Full Text] [Related]
63. New Insights into Neuropeptides Regulation of the Immune System and Hemopoiesis: Effects on Hematologic Malignancies.
Allegra A; Sant'Antonio E; Musolino C; Ettari R
Curr Med Chem; 2022; 29(14):2412-2437. PubMed ID: 34521320
[TBL] [Abstract][Full Text] [Related]
64. A novel silver (I) chelate: cytotoxicity and apoptotic mechanism of action on human hematopoietic malignancies.
Batarseh KI
Leukemia; 2008 Feb; 22(2):448-50. PubMed ID: 17690694
[No Abstract] [Full Text] [Related]
65. Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?
Duetz C; Bachas C; Westers TM; van de Loosdrecht AA
Curr Opin Oncol; 2020 Mar; 32(2):162-169. PubMed ID: 31876546
[TBL] [Abstract][Full Text] [Related]
66. Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies.
Wilson-Robles H; Warry E; Miller T; Jarvis J; Matsushita M; Miller P; Herzog M; Turatsinze JV; Kelly TK; Butera ST; Michel G
PLoS One; 2023; 18(5):e0281796. PubMed ID: 37163491
[TBL] [Abstract][Full Text] [Related]
67. Guest editorial: Connecting multiple aspects of hematologic malignancies toward creation of new therapeutics.
Ishikawa F
Int J Hematol; 2017 May; 105(5):547-548. PubMed ID: 28233193
[No Abstract] [Full Text] [Related]
68. Bendamustine: a new therapeutic option for hematologic malignancies.
Cheson BD
Clin Adv Hematol Oncol; 2008 Sep; 6(9):631-3. PubMed ID: 18827785
[No Abstract] [Full Text] [Related]
69. Destroying malignant white cells.
Baum MS
J N J Dent Assoc; 2008; 79(1):18-9. PubMed ID: 18557488
[No Abstract] [Full Text] [Related]
70. Vaccine therapy and adoptive immunotherapy in hematologic malignancies.
Avigan D
Best Pract Res Clin Haematol; 2008 Sep; 21(3):373-4. PubMed ID: 18790443
[No Abstract] [Full Text] [Related]
71. [Hematological malignancies--a special field of blood system pathology].
Vorob'ev AI; Vorob'ev IA; Kravchenko SK; Kremenetskaia AM; Krivolapov IuA; Frank GA
Ter Arkh; 2007; 79(7):5-10. PubMed ID: 17802782
[No Abstract] [Full Text] [Related]
72. Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy.
Zhao X; Zhang W; Wang L; Zhao WL
Biomark Res; 2013 Aug; 1(1):24. PubMed ID: 24252620
[TBL] [Abstract][Full Text] [Related]
73. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.
Meirow D; Hardan I; Dor J; Fridman E; Elizur S; Ra'anani H; Slyusarevsky E; Amariglio N; Schiff E; Rechavi G; Nagler A; Ben Yehuda D
Hum Reprod; 2008 May; 23(5):1007-13. PubMed ID: 18344563
[TBL] [Abstract][Full Text] [Related]
74. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
75. Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia.
Sawada A; Sakata N; Kishimoto T; Higuchi B; Koyama M; Kondo O; Sato E; Okamura T; Yasui M; Inoue M; Yoshioka A; Kawa K
Leuk Res; 2009 Dec; 33(12):1710-3. PubMed ID: 19596431
[TBL] [Abstract][Full Text] [Related]
76. Epigenetic immunomodulation of hematopoietic malignancies.
Gattei V; Fonsatti E; Sigalotti L; Degan M; Di Giacomo AM; Altomonte M; Calabrò L; Maio M
Semin Oncol; 2005 Oct; 32(5):503-10. PubMed ID: 16210091
[TBL] [Abstract][Full Text] [Related]
77. [Clinical values of biomarkers in hematopoietic malignancies].
Kawaguchi T; Nosaka K
Gan To Kagaku Ryoho; 2009 Jan; 36(1):26-31. PubMed ID: 19151562
[TBL] [Abstract][Full Text] [Related]
78. [Hematopoietic malignancy (leukemia, malignant lymphoma, multiple myeloma)].
Nosaka K; Kawaguchi T
Nihon Rinsho; 2012 May; 70(5):835-9. PubMed ID: 22620009
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
